REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Darya-Varia Laboratoria Tbk (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pt Darya-Varia Laboratoria Tbk Profile Updated: March 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT. Darya Varia Laboratoria Tbk. (DVLA) operates as a producer of medicines and provider of health care & cosmetic products. DVLA has three main business streams, namely: prescription business, consumer health business (over the counter drugs) and export & Toll manufacturing business. DVLA was listed on Indonesia Stock Exchange in 1994 under the Main Board. The company was founded in 1976 and based in Jakarta with its plant located in Bogor.

Headquarters
South Quarter, Tower C, 18Th -19Th Floor, Jl R. A. Kartini Kav 8
Jakarta; Jakarta; Postal Code: 12430

Contact Details: Purchase the Pt Darya-Varia Laboratoria Tbk report to view the information.

Website: http://www.darya-varia.com

Basic Information
Total Employees:
Purchase the Pt Darya-Varia Laboratoria Tbk report to view the information.
Outstanding Shares:
Purchase the Pt Darya-Varia Laboratoria Tbk report to view the information.
Financial Auditors:
Purchase the Pt Darya-Varia Laboratoria Tbk report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
7.87%
Company Performance
Financial values in the chart are available after Pt Darya-Varia Laboratoria Tbk report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.64%
Total operating revenue
-10.29%
Operating profit (EBIT)
-29.08%
EBITDA
-26.11%
Net Profit (Loss) for the Period
-39.61%
Total assets
-3.39%
Total equity
-2.94%
Operating Profit Margin (ROS)
-2.98%
Net Profit Margin
-3.42%
Return on Equity (ROE)
-4.29%
Debt to Equity Ratio
-0.07%
Quick Ratio
-0.15%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?